ArticleEuropean radiology2026
Competitive blood flow from the contralateral vertebral artery signifies a favorable outcome after successful recanalization for acute posterior circulation ischemic stroke.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vertebral Artery Hypoplasia and Posterior Circulation Vulnerability: A Systematic Review of Epidemiological, Hemodynamic, and Clinical Evidence.Neurology international · 2026Review
Corrections and comments
- Commented on by
Authors and funding
14 authors.
Funding
Abstract
objectivesEarly prognosis prediction is challenging after endovascular treatment (EVT) for acute posterior circulation ischemic stroke (PCIS). We evaluated the frequency and prognostic impact of competitive blood flow from the contralateral vertebral artery (CBF-cVA), observed post-recanalization. MATERIALS AND
methodsWe retrospectively screened patients with acute PCIS who underwent EVT with successful recanalization. CBF-cVA was defined as the rapid clearing of the basilar artery and posterior cerebral arteries previously opacified by antegrade reperfusion. The good functional outcomes are defined as a score of 0-3 on the modified Rankin scale (mRS) at 90 days. Logistic regression was used to investigate the association of CBF-cVA and good functional outcomes at 90 days.
resultsA total of 259 patients (median age, 64 years, 74.9% male) were included. CBF-cVA was observable in 44.0% of patients and more frequently in patients with good status of the non-operated vertebral artery which was categorized as good or bad based on the presence of hypoplasia, occlusion, slow flow, or lack of opacification (14.9% vs. 62.1%; p < 0.001) and better collateral score (median 6 vs. 4; p < 0.001). CBF-cVA was associated with good functional outcomes (adjusted OR [95% CI], 3.410 [1.636, 7.105]; p = 0.001), but not with 90-day mortality and symptomatic intracranial hemorrhage (both p > 0.05).
conclusionCBF-cVA was associated with better functional outcomes in patients with PCIS who underwent EVT with successful recanalization. The presence of CBF-cVA was related to the status of the non-operated vertebral artery and better collateral flow. KEY POINTS: Question The prediction of early prognosis continues to pose a significant challenge in the clinical management of patients undergoing thrombectomy for posterior circulation strokes. Findings The presence of competitive blood flow from the contralateral vertebral artery (CBF-cVA) was significantly associated with more favorable 90-day functional outcomes. Clinical relevance CBF-cVA provided a practical, binary imaging assessment after endovascular treatment in patients with acute posterior circulation ischemic stroke. This straightforward tool improved the prediction of favorable clinical outcomes, aiding in guiding treatment strategies after recanalization.
Indexed as
Identifiers
41721848What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.